Legend Capital Leads $17M Round In Chinese Aesthetic Medical Firm PhiSkin

For Digital Subscribers Only

Legend Capital has led a RMB120 million (US$17 million) series B round in PhiSkin, a Shanghai-based aesthetic medical and beauty services provider.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY